Applied DNA Sciences Stock to Reverse Split on Thursday, April 25th (NASDAQ:APDN)

Applied DNA Sciences, Inc. (NASDAQ:APDN) shares are set to reverse split on the morning of Thursday, April 25th. The 1-20 reverse split was announced on Thursday, April 25th. The number of shares owned by shareholders will be adjusted after the closing bell on Thursday, April 25th.

Applied DNA Sciences Stock Performance

APDN traded down $0.04 on Tuesday, reaching $0.29. 811,420 shares of the stock were exchanged, compared to its average volume of 116,854. The company’s 50-day moving average price is $0.49 and its 200 day moving average price is $0.67. Applied DNA Sciences has a fifty-two week low of $0.28 and a fifty-two week high of $1.86.

Applied DNA Sciences (NASDAQ:APDN) last issued its quarterly earnings data on Thursday, February 8th. The technology company reported ($0.09) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.31) by $0.22. The business had revenue of $0.89 million during the quarter, compared to analysts’ expectations of $0.70 million. Applied DNA Sciences had a negative return on equity of 159.93% and a negative net margin of 80.14%. As a group, research analysts predict that Applied DNA Sciences will post -0.63 EPS for the current year.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on APDN. StockNews.com began coverage on Applied DNA Sciences in a report on Sunday. They issued a “hold” rating for the company. HC Wainwright cut their price target on Applied DNA Sciences from $2.00 to $1.50 and set a “buy” rating for the company in a research note on Friday, February 9th.

Hedge Funds Weigh In On Applied DNA Sciences

A hedge fund recently bought a new stake in Applied DNA Sciences stock. Silverberg Bernstein Capital Management LLC acquired a new position in shares of Applied DNA Sciences, Inc. (NASDAQ:APDN) in the 4th quarter, according to its most recent filing with the SEC. The fund acquired 98,301 shares of the technology company’s stock, valued at approximately $61,000. Silverberg Bernstein Capital Management LLC owned approximately 0.72% of Applied DNA Sciences at the end of the most recent quarter. Institutional investors own 22.22% of the company’s stock.

About Applied DNA Sciences

Applied DNA Sciences, Inc, a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services.